<p>(A) Overall survival data for MDS patients stratified by <i>IDH1/2</i> mutational status. (B) Leukemia-free survival data for MDS patients stratified by <i>IDH1/2</i> mutational status. (C) Overall survival data for MDS patients stratified by <i>IDH1</i> mutational status. (D) Leukemia-free survival data for MDS patients stratified by <i>IDH1</i> mutational status. (E) Overall survival data for MDS patients stratified by <i>IDH2</i> mutational status. (F) Leukemia-free survival data for MDS patients stratified by <i>IDH2</i> mutational status.</p
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) with 95% confi...
<p>Patients with more than the median number of <i>CD</i>44<sup>+</sup><i>CD</i>47<sup>+</sup> cells...
<p>(A) Overall survival. (B) Progression-free survival. (C) Locoregional relapse-free survival and (...
<p>(A) Overall survival of MDS patients in the intermediate-1 risk group of IPSS. (B) Overall surviv...
<p>Patients were stratified into 2 to 6 groups by the followings: (a) HSC-CMP score, two groups (1: ...
<p><b>(A) Disease-free survival (DFS) based on the mtDNA somatic mutation status.</b> (B) Overall su...
<p>(A) Overall survival and (B) progression-free survival according to baseline serum miR-21 levels ...
<p>(<b>A</b>) Overall survival rate for 674 patients with LSCC (<b>B</b>) Progression-free survival ...
<p>Kaplan-Meier survival curves for patients from (A) 2002-3 TB Cohort defined by MDR- vs non-MDR st...
<p><i>A–B</i>, OS (<i>A</i>) and DFS (<i>B</i>) for the <i>MAML2</i> rearrangement. <i>C–D</i>, OS (...
<p>Kaplan-Meier survival curves for overall survival and disease progression-free rate.</p
Kaplan-Meier survival curves depicting overall survival (OS) according to tumor size (a), the maximu...
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
Each Kaplan-Meier survival curves represents cancer-specific survival of different age at diagnosis ...
<p>Kaplan-Meier curves of overall survival by histology in (A) all patients, (B) patients with non-m...
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) with 95% confi...
<p>Patients with more than the median number of <i>CD</i>44<sup>+</sup><i>CD</i>47<sup>+</sup> cells...
<p>(A) Overall survival. (B) Progression-free survival. (C) Locoregional relapse-free survival and (...
<p>(A) Overall survival of MDS patients in the intermediate-1 risk group of IPSS. (B) Overall surviv...
<p>Patients were stratified into 2 to 6 groups by the followings: (a) HSC-CMP score, two groups (1: ...
<p><b>(A) Disease-free survival (DFS) based on the mtDNA somatic mutation status.</b> (B) Overall su...
<p>(A) Overall survival and (B) progression-free survival according to baseline serum miR-21 levels ...
<p>(<b>A</b>) Overall survival rate for 674 patients with LSCC (<b>B</b>) Progression-free survival ...
<p>Kaplan-Meier survival curves for patients from (A) 2002-3 TB Cohort defined by MDR- vs non-MDR st...
<p><i>A–B</i>, OS (<i>A</i>) and DFS (<i>B</i>) for the <i>MAML2</i> rearrangement. <i>C–D</i>, OS (...
<p>Kaplan-Meier survival curves for overall survival and disease progression-free rate.</p
Kaplan-Meier survival curves depicting overall survival (OS) according to tumor size (a), the maximu...
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
Each Kaplan-Meier survival curves represents cancer-specific survival of different age at diagnosis ...
<p>Kaplan-Meier curves of overall survival by histology in (A) all patients, (B) patients with non-m...
<p>Kaplan-Meier curves showing overall survival (A) and progression free survival (B) with 95% confi...
<p>Patients with more than the median number of <i>CD</i>44<sup>+</sup><i>CD</i>47<sup>+</sup> cells...
<p>(A) Overall survival. (B) Progression-free survival. (C) Locoregional relapse-free survival and (...